Daniel Gil
InvestorVenture Partner at Visionary Ventures
About
A pharmaceutical R&D veteran of over 30 years and current CEO of Pelage Pharmaceuticals. Formerly VP of Research Technologies and Portfolio at Allergan; holds a biology degree from Harvard and a PhD in pharmacology from the University of Pennsylvania.
Colleagues at Visionary Ventures
Bill Carpou
Investor at Visionary Ventures
Bob Avery
Investor at Visionary Ventures
Dick Lindstrom
Investor at Visionary Ventures
Dr. Bob Avery
Investment Committee at Visionary Ventures
Dr. Dick Lindstrom
Investment Committee at Visionary Ventures
Dr. Ehsan Sadri
Investment Committee at Visionary Ventures
Dr. Toby Tyson
Investment Committee at Visionary Ventures
Ehsan Sadri
Investor at Visionary Ventures




